+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

FDA Regulations and New Legislation for Marketing Cosmetics in the U.S - Webinar (Recorded)

  • Webinar

  • 120 Minutes
  • April 2019
  • Region: United States
  • Compliance Online
  • ID: 4899708
Why Should You Attend:

The webinar will cover laws and regulations for successful marketing and compliance of cosmetics in the U.S. It will help clarify what claims and product labeling are appropriate for cosmetics to market them successfully and avoid problems with FDA compliance. Current FDA Warning letters will be discussed to understand FDA’s changing views on cosmetic enforcement. Adverse Event Reporting for Cosmetics will be discussed with focus on how this will change under the Personal Care Products Safety Act.

Learning Objectives:

To learn FDA Labeling requirements for Cosmetics & Personal Care Products
To understand cosmetic claims and compliance issues and how to avoid FDA issues
Learn what “Cosmeceuticals” are and how they can be legally marketed
Learn about 2015 Proposed Cosmetics legislation, the Personal Care Products Safety Act
Gain understanding of Good Manufacturing Practice systems for Cosmetics & Coming GMP regulations
Learn Adverse Event Labeling & Reporting requirements for cosmetics and how these will change under the Personal Care Products Safety Act
Areas Covered in the Webinar:

Laws and Regulations Applicable to U.S. Cosmetics
Cosmetic Labeling Requirements
Adverse Event Reporting for Cosmetics
Cosmetic Claims and Compliance Issues
Current Cosmetic GMP Requirements
2015 Proposed Cosmetics Legislation: The Personal Care Products Safety Act

Speakers

Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as director of regulatory affairs for the Americas for Cadbury Adams. Prior to that she was director of regulatory affairs for the Adams Division of Pfizer and associate director of regulatory affairs for the Warner-Lambert company. She also served as director of regulatory affairs for Lederle Consumer Healthcare and as associate director of marketed product support for Lederle Laboratories and associate director of regulatory affairs for Wyeth. She currently works as a regulatory consultant.